Neurocysticercosis: treatment with albendazole and dextrochloropheniramine (preliminary report).
Agapejev
S
S
Meira
D A
DA
Barraviera
B
B
Machado
J M
JM
Pereira
P C
PC
Mendes
R P
RP
Kamegasawa
A
A
Curi
P R
PR
D015766:Albendazole; D000871:Anthelmintics / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D002493:Central Nervous System Diseases / Q000188:drug therapy*; D002744:Chlorpheniramine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003551:Cysticercosis / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans
D000871:Anthelmintics; D001562:Benzimidazoles; C018904:dexchlorpheniramine; D002744:Chlorpheniramine; D015766:Albendazole